Benzylpenicilloyl Polylysine is used as a skin-testing reagent to detect immunoglobulin E antibodies in people with a history of penicillin allergy. The quantitation of in vitro IgE antibodies to the benzylpenicilloyl determinant is a useful tool for evaluating allergic subjects.

• Acetamides
• Acetates
• Acids, Acyclic
• Amides
• Antibacterials for Systemic Use
• Antiinfectives for Systemic Use
• Aza Compounds
• Azabicyclo Compounds
• Benzene Derivatives
• Beta-Lactam Antibacterials, Penicillins
• beta-Lactams
• Fatty Acids
• Fatty Acids, Volatile
• Lactams
• Lipids
• Penicillins
• Sulfur Compounds

For use as a adjunct in assessing the risk of administering penicillin (benzylpenicillin or penicillin G).

• Penicillin Allergy
• Beta-lactam antibiotic allergy

Benylpenicilloyl polylysine is penicilloyl bound to polylysine and is considered to be the major determinant of penicillin metabolism; it is used as a skin-testing reagent to detect immunoglobulin E antibodies in people with a history of penicillin allergy. If skin testing using benzylpenicilloyl and penicillin G (as the sole source of minor determinants) is negative, approximately 97% of patients with a negative skin test will tolerate penicillin.

Symptoms of overdose include urticaria, generalized pruritus, local swelling, generalized flushing, anaphylaxis, bronchospasm, fainting and maculopapular eruption.

• Humans and other mammals

• J01CR — Combinations of penicillins, incl. beta-lactamase inhibitors
• J01C — BETA-LACTAM ANTIBACTERIALS, PENICILLINS
• J01 — ANTIBACTERIALS FOR SYSTEMIC USE
• J — ANTIINFECTIVES FOR SYSTEMIC USE

• 36:30.00

• Allerquest llc

• Allerquest LLC
• Schwarz Pharma Inc.
• Taylor Pharmaceuticals